Adenosine receptor agonists for promotion of dermal wound healing
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Wound healing is a dynamic and complex process that involves a well coordinated, highly regulated series of events including inflammation, tissue formation, revascularization and tissue remodeling. However, this orderly sequence is impaired in certain pathophysiological conditions such as diabetes mellitus, venous insufficiency, chronic glucocorticoid use, aging and malnutrition. Together with proper wound care, promotion of the healing process is the primary objective in the management of chronic poorly healing wounds. Recent studies have demonstrated that A2A adenosine receptor agonists promote wound healing in normal and diabetic animals and one such agonist, Sonedenoson, is currently being evaluated as a prospective new therapy of diabetic foot ulcers. We will review the mechanisms by which adenosine receptor activation affects the function of the cells and tissues that participate in wound healing, emphasizing the potential beneficial impact of adenosine receptor agonists in diabetic impaired healing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of Wound Healing by Growth Factors and Cytokines
WERNER, S., & GROSE, R. (2003) · Physiological Reviews · doi:10.1152/physrev.2003.83.3.835 · Cited by 3,629 · cited 1×
“through stimulation of fibroblasts and epithelial cells [4].”
BackgroundInternational Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431 · cited 1×
“of epithelial cells in skin and visceral organs, inflammation, neuroprotection and cancer [13, 14].”
BackgroundThellung, S., Florio, T., Maragliano, A., Cattarini, G., & Schettini, G. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00104-6 · Cited by 113
Cited by
Current wound healing procedures and potential care
Dreifke, M. B., Jayasuriya, A. A., & Jayasuriya, A. C. (2015) · Materials Science and Engineering: C · doi:10.1016/j.msec.2014.12.068 · Cited by 538
Recent developments in adenosine receptor ligands and their potential as novel drugs
Müller, C. E., & Jacobson, K. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.017 · Cited by 431
Adenosine A 2A Receptor as a Drug Discovery Target
de Lera Ruiz, M., Lim, Y.-H., & Zheng, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4011669 · Cited by 276
Altavilla, D., Bitto, A., Polito, F., Marini, H., Minutoli, L., Stefano, V., Irrera, N., Cattarini, G., & Squadrito, F. (2009) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152509789541909 · Cited by 107
“Indeed several experimental findings have pointed out the key role played by the adenosine A2A receptor in promoting the wound healing and neovascularisation [46-49].”
BackgroundPolydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing
Galeano, M., Pallio, G., Irrera, N., Mannino, F., Bitto, A., Altavilla, D., Vaccaro, M., Squadrito, G., Arcoraci, V., Colonna, M. R., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14111103 · Cited by 79
Metadata
- Authors
- Valls, M. D., Cronstein, B. N., & Montesinos, M. C.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 77
- Issue
- 7
- Pages
- 1117-1124
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W1980483140
- Cited by
- 109
- References
- 4
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.